Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network.

Antonio Vitale Jurgen SotaLaura ObiciNicola RiccoMaria Cristina MaggioMarco CattaliniPiero RuscittiFrancesco Caso Raffaele MannaOmbretta ViapianaValeria CaggianoGiacomo EmmiAntonella InsalacoDavide MontinFrancesco LicciardiAlessandra SorianoLorenzo DagnaCarlo SalvaraniVittoria LamacchiaJosé Hernández-RodríguezRoberto GiacomelliBruno FredianiAlessandra Renieri Claudia Fabiani

Published in: Mediators of inflammation (2020)

Colchicine monotherapy is useful in a low percentage of TRAPS patients; nevertheless, it could be attempted in patients with milder phenotypes and at a lower risk of developing reactive amyloidosis.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
clinical trial
randomized controlled trial
open label
big data
case report
patient reported outcomes
binding protein
replacement therapy
double blind